France vs New Caledonia: The number of people with susceptibility test result for rifampicin
France
17
in 2021
New Caledonia
15
in 2021
France rank
134th
New Caledonia rank
135th
The number of people with susceptibility test result for rifampicin over time
- France
- New Caledonia
How they compare
France currently reports 17 against 15 in New Caledonia, a difference of 2.
That makes France's figure about 1.1 times New Caledonia's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was France ahead.
France ranks 134th and New Caledonia ranks 135th of 155 countries.
Across the 2 decades both report, France averaged higher in 1 and New Caledonia in 1.
Head to head by decade
| Decade | France | New Caledonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,801 | 21.33 | 1,780 | France |
| 2020s | 18.5 | 19.5 | 1 | New Caledonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, France or New Caledonia?
- France, at 17 against 15 in New Caledonia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between France and New Caledonia?
- 2, with France ahead.
- How many years of comparable data are there for France and New Caledonia?
- 5 years are reported by both, from 2017 to 2021.
- How do France and New Caledonia rank globally for the number of people with susceptibility test result for rifampicin?
- France ranks 134th and New Caledonia ranks 135th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.